Literature DB >> 25747754

Mineralocorticoid receptor blockade prevents Western diet-induced diastolic dysfunction in female mice.

Brian Bostick1, Javad Habibi2, Vincent G DeMarco3, Guanghong Jia2, Timothy L Domeier4, Michelle D Lambert4, Annayya R Aroor2, Ravi Nistala5, Shawn B Bender6, Mona Garro2, Melvin R Hayden2, Lixin Ma7, Camila Manrique2, James R Sowers8.   

Abstract

Overnutrition/obesity predisposes individuals, particularly women, to diastolic dysfunction (DD), an independent predictor of future cardiovascular disease. We examined whether low-dose spironolactone (Sp) prevents DD associated with consumption of a Western Diet (WD) high in fat, fructose, and sucrose. Female C57BL6J mice were fed a WD with or without Sp (1 mg·kg(-1)·day(-1)). After 4 mo on the WD, mice exhibited increased body weight and visceral fat, but similar blood pressures, compared with control diet-fed mice. Sp prevented the development of WD-induced DD, as indicated by decreased isovolumic relaxation time and an improvement in myocardial performance (<Tei index) and septal annular velocity (<E'-to-A' ratio), as assessed by echocardiography, as well as decreased diastolic relaxation time/increased diastolic initial filling rate, as assessed by MRI. The relationship between passive sarcomere length of cardiac myocytes and ventricular pressure was monitored using di-8-ANEPPS staining of the t-tubule network in hearts ex vivo. Sp administration led to longer sarcomere lengths at each pressure indicative of improved ventricular compliance in WD-fed mice. Sp also prevented left ventricular hypertrophy, interstitial fibrosis, and oxidative stress. Sp prevented the WD-induced increased expression of myocardial proinflammatory M1 macrophage markers monocyte chemoattractant protein-1 and CD11c and increased the expression of the anti-inflammatory M2 macrophage marker CD206. These findings demonstrate that WD-induced DD is associated with increased oxidant stress, fibrosis, and immune dysregulation. Mineralocorticoid receptor antagonism enhanced M2 macrophage polarization and ameliorated oxidant stress and fibrosis. This work supports a novel blood pressure-independent effect of MR antagonism as a strategy to prevent diet-induced DD in women. Mineralocorticoid antagonism; low-dose spironolactone; aldosterone;high-fat diet; high-fructose diet; oxidative stress; inflammation; cardiac hypertrophy; myocardial compliance.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  aldosterone; cardiac hypertrophy; high-fat diet; high-fructose diet; inflammation; low-dose spironolactone; mineralocorticoid antagonism; myocardial compliance; oxidative stress

Mesh:

Substances:

Year:  2015        PMID: 25747754      PMCID: PMC4551127          DOI: 10.1152/ajpheart.00898.2014

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  70 in total

Review 1.  Aldosterone and vascular inflammation.

Authors:  Nancy J Brown
Journal:  Hypertension       Date:  2008-01-02       Impact factor: 10.190

Review 2.  Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies.

Authors:  Kavita Sharma; David A Kass
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

3.  Comparative analysis of telmisartan and olmesartan on cardiac function in the transgenic (mRen2)27 rat.

Authors:  Vincent G DeMarco; Megan S Johnson; Javad Habibi; Lakshmi Pulakat; Rukhsana Gul; Melvin R Hayden; Roger D Tilmon; Kevin C Dellsperger; Nathaniel Winer; Adam T Whaley-Connell; James R Sowers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-05       Impact factor: 4.733

Review 4.  Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.

Authors:  Chirag H Mandavia; Annayya R Aroor; Vincent G Demarco; James R Sowers
Journal:  Life Sci       Date:  2012-11-09       Impact factor: 5.037

5.  Obesity-related alterations in cardiac lipid profile and nondipping blood pressure pattern during transition to diastolic dysfunction in male db/db mice.

Authors:  Vincent G Demarco; David A Ford; Erik J Henriksen; Annayya R Aroor; Megan S Johnson; Javad Habibi; Lixin Ma; Ming Yang; Carolyn J Albert; John W Lally; Caleb A Ford; Mujalin Prasannarong; Melvin R Hayden; Adam T Whaley-Connell; James R Sowers
Journal:  Endocrinology       Date:  2012-11-09       Impact factor: 4.736

6.  The Impact of Overnutrition on Insulin Metabolic Signaling in the Heart and the Kidney.

Authors:  Lakshmi Pulakat; Vincent G DeMarco; Adam Whaley-Connell; James R Sowers
Journal:  Cardiorenal Med       Date:  2011-04-15       Impact factor: 2.041

7.  Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines.

Authors:  Christine Guo; Vincent Ricchiuti; Bill Q Lian; Tham M Yao; Patricia Coutinho; José R Romero; Jianmin Li; Gordon H Williams; Gail K Adler
Journal:  Circulation       Date:  2008-04-21       Impact factor: 29.690

Review 8.  Molecular and cellular basis for diastolic dysfunction.

Authors:  Loek van Heerebeek; Constantijn P M Franssen; Nazha Hamdani; Freek W A Verheugt; G Aernout Somsen; Walter J Paulus
Journal:  Curr Heart Fail Rep       Date:  2012-12

9.  Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro.

Authors:  M de Gasparo; U Joss; H P Ramjoué; S E Whitebread; H Haenni; L Schenkel; C Kraehenbuehl; M Biollaz; J Grob; J Schmidlin
Journal:  J Pharmacol Exp Ther       Date:  1987-02       Impact factor: 4.030

Review 10.  Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease?

Authors:  Shawn B Bender; Adam P McGraw; Iris Z Jaffe; James R Sowers
Journal:  Diabetes       Date:  2013-02       Impact factor: 9.461

View more
  35 in total

1.  New roles of aldosterone and mineralocorticoid receptors in cardiovascular disease: translational and sex-specific effects.

Authors:  Ana Paula Davel; Iris Z Jaffe; Rita C Tostes; Frederic Jaisser; Eric J Belin de Chantemèle
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-06-29       Impact factor: 4.733

2.  Endothelial sodium channel activation promotes cardiac stiffness and diastolic dysfunction in Western diet fed female mice.

Authors:  James R Sowers; Javad Habibi; Guanghong Jia; Brian Bostick; Camila Manrique-Acevedo; Guido Lastra; Yan Yang; Dongqing Chen; Zhe Sun; Timothy L Domeier; William Durante; Adam T Whaley-Connell; Michael A Hill; Frederic Jaisser; Vincent G DeMarco; Annayya R Aroor
Journal:  Metabolism       Date:  2020-04-07       Impact factor: 8.694

Review 3.  Role of mineralocorticoid receptor activation in cardiac diastolic dysfunction.

Authors:  Guanghong Jia; Yan Jia; James R Sowers
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-10-29       Impact factor: 5.187

Review 4.  Mineralocorticoid receptors in the pathogenesis of insulin resistance and related disorders: from basic studies to clinical disease.

Authors:  Guanghong Jia; Warren Lockette; James R Sowers
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2021-01-13       Impact factor: 3.619

Review 5.  The role of mineralocorticoid receptor signaling in the cross-talk between adipose tissue and the vascular wall.

Authors:  Guanghong Jia; Annayya R Aroor; James R Sowers
Journal:  Cardiovasc Res       Date:  2017-07-01       Impact factor: 10.787

6.  Endothelial Mineralocorticoid Receptor Mediates Diet-Induced Aortic Stiffness in Females.

Authors:  Guanghong Jia; Javad Habibi; Annayya R Aroor; Luis A Martinez-Lemus; Vincent G DeMarco; Francisco I Ramirez-Perez; Zhe Sun; Melvin R Hayden; Gerald A Meininger; Katelee Barrett Mueller; Iris Z Jaffe; James R Sowers
Journal:  Circ Res       Date:  2016-02-15       Impact factor: 17.367

Review 7.  Obesity and cardiovascular disease in women.

Authors:  Camila Manrique-Acevedo; Bhavana Chinnakotla; Jaume Padilla; Luis A Martinez-Lemus; David Gozal
Journal:  Int J Obes (Lond)       Date:  2020-02-17       Impact factor: 5.095

8.  Body Mass Index Predicts 24-Hour Urinary Aldosterone Levels in Patients With Resistant Hypertension.

Authors:  Tanja Dudenbostel; Lama Ghazi; Mingchun Liu; Peng Li; Suzanne Oparil; David A Calhoun
Journal:  Hypertension       Date:  2016-08-15       Impact factor: 10.190

Review 9.  Cellular mechanisms underlying obesity-induced arterial stiffness.

Authors:  Annayya R Aroor; Guanghong Jia; James R Sowers
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-11-22       Impact factor: 3.619

10.  Preventive and chronic mineralocorticoid receptor antagonism is highly beneficial in obese SHHF rats.

Authors:  G Youcef; A Olivier; N Nicot; A Muller; C Deng; C Labat; R Fay; R-M Rodriguez-Guéant; C Leroy; F Jaisser; F Zannad; P Lacolley; L Vallar; A Pizard
Journal:  Br J Pharmacol       Date:  2016-04-26       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.